Stock vs Stock Comparison

McKesson Corporation vs Johnson & Johnson

MCK wins the Tale of the Tape 7–2.

MCK$736.78
JNJ$222.89

🏆 Tale of the Tape

72
MCKJNJ
0.9%Profitability (Net Margin)28.5%
19.3xValuation (P/E)26.1x
27.0%Efficiency (ROIC)18.3%
5/9Health (Piotroski F)4/9
6.1Safety (Altman Z)4.0
16.2%Growth (Rev YoY)6.0%
0.87Risk (Sharpe 1Y)2.69
-45.36xBalance Sheet (D/E)1.44x
4.95%FCF Yield3.25%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.267
252-Day Correlation
0.251
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricMCKJNJ
Market Cap$89.2B$542.4B
P/E Ratio19.3x26.1x
Forward P/E14.8x17.7x
P/B-41.02x6.68x
Dividend Yield0.44%2.38%
Beta0.350.26

Quantitative Metrics

MetricMCKJNJ
DCF Fair Value$632.61$134.24
DCF Upside-26.8%-43.6%
Piotroski F5/94/9
Altman Z6.053.97
Beneish M-2.44-2.27
FCF Yield4.95%3.25%
Net Debt/EBITDA-0.2x0.5x
ROIC27.0%18.3%
WACC7.8%7.7%
ROIC – WACC19.1pp10.5pp
Gross Margin3.7%67.9%
Net Margin0.9%28.5%
Rev Growth YoY16.2%6.0%
Sharpe (1Y)0.872.69
Max Drawdown 3Y-23.9%-16.0%
FCF Payout Ratio7%64%

MCK Price

Loading chart...

JNJ Price

Loading chart...

ETF Exposure

MCK found in:

IYK3.95%
XLV1.75%
VHT1.63%
XHS1.47%
ONEV0.82%
ONEO0.65%
QUS0.53%
MGV0.50%
SCHG0.46%
VIG0.45%
VFMV0.44%
DGRW0.42%
VTV0.39%
IWF0.36%
SPYV0.33%
VONG0.30%
ESGV0.22%
VFMO0.21%
RSP0.20%
SCHX0.20%
SCHB0.18%
VFVA0.18%
IVV0.17%
SPLG0.17%
VOO0.16%
ITOT0.15%
VONE0.15%
SPY0.15%
URTH0.14%
VTI0.14%
SPTM0.13%
ACWI0.11%
VT0.09%
IWD0.03%

JNJ found in:

XLV10.42%
IYH10.14%
VHT8.84%
HDV6.84%
MTUM3.76%
DIA2.83%
MGV2.75%
DGRO2.64%
VIG2.49%
VYM2.30%
VTV2.16%
DGRW2.02%
SCHV2.02%
IWD1.94%
QUS1.81%
XPH1.74%
VONV1.69%
NOBL1.58%
VFMV1.42%
VFMO1.02%
SCHX0.96%
SPYG0.94%
SDY0.93%
VOO0.90%
SCHB0.90%
SPY0.87%
IVV0.85%
VONE0.84%
SPTM0.81%
VTI0.80%
SPYV0.79%
SPLG0.76%
ITOT0.75%
URTH0.70%
ACWI0.57%
VT0.49%
RSP0.21%
VFVA0.15%
ONEO0.05%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

MCK vs JNJ: Head-to-Head Analysis

McKesson Corporation (MCK) and Johnson & Johnson (JNJ) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, MCK leads 7–2 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, MCK generates a return on invested capital (ROIC) of 27.0% compared to JNJ's 18.3%. This suggests MCK is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between MCK and JNJ is 0.267, indicating low correlation, making them an effective diversification pair in a portfolio context.

MCK appears in 34 ETFs tracked by SecuritiesDB, while JNJ appears in 39 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, MCK or JNJ?

Our quantitative analysis compares MCK and JNJ across nine fundamental dimensions. MCK wins the Tale of the Tape 7–2. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are MCK and JNJ correlated?

The 252-day correlation between MCK and JNJ is 0.267. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.